Get started
OXURIONOO

OXURION

0.1650EURD
−0.0094−5.39%
At close at Mar 14, 16:35 GMT
EUR
No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Seasonals

OXUR fundamentals

Key facts

Market capitalization‪600.33 K‬EUR
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−26.40EUR
Founded2006
Employees (FY)19
CEOGhoson Pascal
Websiteoxurion.com
About

Oxurion NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA brand name. The company was founded by Desire Collen in 1991 and is headquartered in Leuven, Belgium.

Ownership
‪‪1.34 M‬‬
Free Float shares
‪‪1.12 M‬‬ (83.83%)
Closely held shares
‪‪216.11 K‬‬ (16.17%)
Free Float shares
‪‪1.12 M‬‬ (83.83%)
Closely held shares
‪‪216.11 K‬‬ (16.17%)
Capital structure
Market cap
‪‪600.33 K‬‬
Debt
‪‪11.91 M‬‬
Cash & equivalents
‪‪119.00 K‬‬
Enterprise value
‪‪12.40 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪600.33 K‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
2.55x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
2.55x
Valuation ratios
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪0.00‬
‪5.00‬
‪10.00‬
‪15.00‬
‪20.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−325,000%‬
‪−245,000%‬
‪−165,000%‬
‪−85,000%‬
‪−5,000%‬
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−18.00 M‬‬
‪‪−12.00 M‬‬
‪‪−6.00 M‬‬
‪0.00‬
‪‪6.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−3.30 M‬‬
‪‪−2.20 M‬‬
‪‪−1.10 M‬‬
‪0.00‬
‪‪1.10 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−3.30 M‬‬
‪‪−2.20 M‬‬
‪‪−1.10 M‬‬
‪0.00‬
‪‪1.10 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Vials
Royalties
By country
Period: 2023
Belgium

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
Estimate
Earnings
Next:Mar 17, 2025
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−3.60 K‬‬
‪‪−2.70 K‬‬
‪‪−1.80 K‬‬
‪−900.00‬
‪0.00‬
Estimate

Dividends

Dividend yield, history and sustainability

OXUR does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−16.00 M‬‬
‪‪−8.00 M‬‬
‪0.00‬
‪‪8.00 M‬‬
‪‪16.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪5.00 M‬‬
‪‪10.00 M‬‬
‪‪15.00 M‬‬
‪‪20.00 M‬‬
Assets
Liabilities